Bandingkan Harga & Kinerja Jaya Real Property Tbk. (JRPT) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jaya Real Property Tbk. dan Organon Pharma Indonesia Tbk.: Jaya Real Property Tbk. diperdagangkan di Rp1.115 (kapitalisasi pasar 14,52 T, volume 24 jam 867,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jaya Real Property Tbk. jauh lebih besar — sekitar 139,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JRPT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 14,52 T | 104,4 M |
Volume | 867,1 rb | — |
Lot | 8,67 rb | — |
Perputaran | 961,9 jt | — |
Harga Rata-rata | 1.109,32 | — |
Nilai Transaksi | 961,9 jt | — |
Harga Ekuilibrium Indikatif | 1.115 | — |
Volume Ekuilibrium Indikatif | 2,5 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jaya Real Property Tbk.
PT Jaya Real Property Tbk (the Company) was established under Domestic Investment Law on May 25, 1979, based on the notarial deed No. 36 of Hobropoerwanto, S.H., at that time a notary in Jakarta, and amended with notarial deed No. 14 of the same notary as of December 6, 1979.. Jaya Real Property is the largest property company (in terms of market capitalization) listed on the JSX. It is a wholly owned subsidiary of PT Pembangunan Jaya (the Jaya Group), which is the oldest established property developer.
Selengkapnya di halaman JRPT →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
